Neuro and Medical Oncologist Manmeet Ahluwalia, MD, Joins Miami Cancer Institute as Deputy Director, Chief Scientific Officer and Chief of Solid Tumor Medical Oncology

Board-certified neuro-oncologist and medical oncologist Manmeet Ahluwalia, MD, FACP, MBA, joins Miami Cancer Institute, a part of Baptist Health South Florida, as deputy director, chief scientific officer and chief of solid tumor medical oncology. Board-certified in internal medicine, medical oncology, neuro-oncology and hematology, Dr. Ahluwalia is a leading expert in brain metastases and primary brain tumors. He is fluent in English, Hindi and Punjabi. “I would like to welcome Dr. Ahluwalia to Miami Cancer Institute,” said Leonard Kalman, MD, executive deputy director and chief medical officer at Miami Cancer Institute. “As deputy director, chief scientific officer and chief of solid...

read more

Vaccinations Roll Out for Florida Assisted Living Facilities

Last week, Florida Assisted Living Facilities’ (ALFs) residents and staff began receiving the COVID-19 vaccinations as part of Florida’s partnership with CVS and Walgreens.[i] This vaccine administration is the first phase of the State of Florida’s plan in administering the vaccine to the most vulnerable population: long term care facility residents and staff, persons over the age of 65, and health care personnel with direct patient contact.[ii] However, there are still many ALFs who have yet to receive the vaccinations, which has caused frustration for some.[iii] This frustration has prompted the State of Florida to contract with CDR Health, a private firm that operates COVID-19 testing...

read more

Featured Video

How to help Covid-19 long-haulers

Those of us who try to prepare communities for outbreaks of infectious diseases have a saying: Once you’ve seen one pandemic, you’ve seen one pandemic. In other words, each deadly outbreak is different, and brings with it new challenges. As members of a team that helps the nation’s largest public health-care system prepare for and respond to outbreaks, we are on constant alert. In the past decade alone, health-care professionals around the world have fought back many of these invisible threats, from Ebola in 2014 to Zika in 2016. Now, we battle Covid-19, and it is without question much more difficult to manage. We’re learning more and more about the virus each day, and one of its biggest...

read more

Cleveland Clinic Weston Offers Monoclonal Antibody Therapy for COVID-19

Cleveland Clinic Florida’s Weston hospital is now offering a new treatment option to patients with COVID-19. The monoclonal antibody treatment, Bamlanivimab is now available to patients with pre-existing health conditions who are most at risk of poor outcomes from COVID-19. The treatment was approved by Emergency Use Authorization by the FDA in November 2020. A second therapy, using a cocktail of Casirivimab and Imdevimab will be offered in the coming weeks. The two FDA approved monoclonal antibody treatments work to neutralize the COVID-19 virus in the body and are given to non-hospitalized COVID-19 patients. Patients receive the treatment in the outpatient setting via an infusion and...

read more